SCPH logo
SCPH NASDAQ US

scPharmaceuticals Inc. - Common Stock

Healthcare · Pharmaceuticals Website · IPO Nov 2017
$5.67
+0.0 (+0.0%)
3
Quality Score
fail
Mkt Cap
$304.4M
ROE
-437.5%
Margin
-183.6%
D/E
385.51
Beta
0.45
52W
$2–$6

Wall Street Consensus

10 analysts · Feb 2026
2
Strong Buy
4
Buy
4
Hold
0
Sell
0
Strong Sell
60.0%
Buy Rating

Price Chart

Similar Stocks

SIGA
SIGA Technologies Inc
P/E 5.9
$437.5M
PLYX
Polaryx Therapeutics, Inc
NMRA
Neumora Therapeutics Inc
$299.1M
LENZ
LENZ Therapeutics Inc
$500.6M
EOLS
Evolus Inc
$431.1M
CNTX
Context Therapeutics Inc
$135.1M

Earnings

Beat rate: 25.0%
Next Report May 12, 2026
EPS Estimate: $-0.11
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.11 — —
Jun 2025 $-0.30 $-0.34 $-0.04
Mar 2025 $-0.30 $-0.37 $-0.07
Dec 2024 $-0.39 $-0.35 +$0.04

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) — -437.5% -437.5% -437.5% -437.5% -437.5%
P/E (TTM) — — — — — —
Net Margin -112.4% -183.6% -183.6% -183.6% -183.6% -183.6%
Gross Margin 68.8% 68.5% 68.5% 68.5% 68.5% 68.5%
D/E Ratio — 385.51 385.51 385.51 385.51 385.51
Current Ratio 3.85 3.85 3.85 3.85 3.85 3.85

Key Ratios

ROA (TTM)
-90.9%
P/S (TTM)
6.09
P/B
13.3
EPS (TTM)
$-1.81
CF/Share
$-1.37
52W High
$6.28
52W Low
$1.94
$1.94 52-Week Range $6.28

How does SCPH compare to Pharmaceuticals peers?

Peer group: Micro-cap Pharmaceuticals (All) · 171 companies

SCPH AARD ACB ACRS ADIL

SCPH valuation vs Pharmaceuticals peers

P/E ratio
—
▼ 0% below peers (22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
6.1
▲ 23% above peers (5.0)
vs Peers
vs Industry
Pricier
P/B ratio
13.3
▲ 527% above peers (2.1)
vs Peers
vs Industry
Overvalued
Div yield
—
▼ 0% below peers (2.0%)
vs Peers
vs Industry
Low yield

SCPH profitability vs Pharmaceuticals peers

ROE
-437.5%
▼ 706% below peers (-54.3%)
vs Peers
vs Industry
Weak
Net margin
-183.6%
▼ 287% below peers (-47.4%)
vs Peers
vs Industry
Weak
Gross margin
68.5%
▲ 0% above peers (68.3%)
vs Peers
vs Industry
Weak
ROA
-90.9%
▼ 143% below peers (-37.4%)
vs Peers
vs Industry
Weak

SCPH financial health vs Pharmaceuticals peers

D/E ratio
385.5
▲ 24933% above peers (1.5)
vs Peers
vs Industry
High debt
Current ratio
3.9
▲ 15% above peers (3.4)
vs Peers
vs Industry
In line
Beta
0.5
▼ 53% below peers (0.9)
vs Peers
vs Industry
More volatile

SCPH fundamentals radar

SCPH Peer median Industry

SCPH profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

SCPH vs peers: key metrics

Latest News

No related news yet